MeVis Medical Solutions AG provided earnings guidance for the fiscal year 2021-2022. For the year, the company expected sales to remain stable compared to the previous year at €16.0 million to €16.5 million. In addition to the slight decline in sales with the customer Hologic, slightly increasing sales revenues are expected in the area of development services.

For earnings before interest and taxes (EBIT), also expect stability in the range of €4.0 million to €4.5 million. The forecast sales stability, with an expected break-even result from exchange rate differences, is the main driver for the unchanged outlook for EBIT.